1 |
Sharp A, Chappell LC, Dekker G, et al. Placental growth factor informed management of suspected pre-eclampsia or fetal growth restriction: the MAPPLE cohort study [J]. Pregnancy Hypertens, 2018, 14: 228-233.
|
2 |
Murthi P, Pinar AA, Dimitriadis E, et al. Inflammasomes-a molecular link for altered immunoregulation and inflammation mediated vascular dysfunction in preeclampsia [J]. Int J Mol Sci, 2020, 21(4): 1406.
|
3 |
Imtiaz F, Shafique K, Mirza S, et al. Neutrophil lymphocyte ratio as a measure of systemic inflammation in prevalent chronic diseases in Asian population [J]. Int Arch Med, 2012, 5(1): 2.
|
4 |
Yücel B, Ustun B. Neutrophil to lymphocyte ratio, platelet to lymphocyte ratio, mean platelet volume, red cell distribution width and plateletcrit in preeclampsia [J]. Pregnancy Hypertens, 2017, 7: 29-32.
|
5 |
谢幸, 孔北华, 段涛. 妇产科学 [M]. 9版. 北京: 人民卫生出版社, 2018: 83-84.
|
6 |
Eastwood KA, Hunter AJ, Patterson CC, et al. Placental vascularization indices and prediction of pre-eclampsia in high-risk women [J]. Placenta, 2018, 70: 53-59.
|
7 |
杨青, 王岩岩, 赵雪莲, 等. 子痫前期相关高危因素的临床研究 [J]. 河北医药, 2016, 38(24): 3789-3791, 3795.
|
8 |
Aghamohammadi A, Nooritajer M. Maternal age as a risk factor for pregnancy outcomes: maternal, fetal and neonatal complication [J]. Afr J Pharm Pharmaco, 2011, 5: 264-269.
|
9 |
郭惠萍, 沈丽丹. 子痫前期孕妇炎症反应研究 [J]. 交通医学, 2020, 34(6): 643-644.
|
10 |
Kang SY, Wang Y, Zhou LP, et al. New indicators in evaluation of hemolysis, elevated liver enzymes, and low platelet syndrome: A case-control study [J]. World J Clin Cases, 2021, 9(6): 1259-1270.
|
11 |
万学红, 卢雪峰. 诊断学 [M]. 9版. 北京: 人民卫生出版社, 2018: 249.
|
12 |
Canzoneri BJ, Lewis DF, Groome L, et al. Increased neutrophil numbers account for leukocytosis in women with preeclampsia [J]. Am J Perinatol, 2009, 26: 729-732.
|
13 |
Shen XH, Chen Q, Shi Y, et al. Association of neutrophil/lymphocyte ratio with long-term mortality after ST elevation myocardial infarction treated with primary percutaneous coronary intervention [J]. Chin Med J (Engl), 2010, 123(23): 3438-3443.
|
14 |
Li H, Zhou Y, Ma Y, et al. The prognostic value of the platelet-to-lymphocyte ratio in acute coronary syndrome:a systematic review and meta-analysis [J]. Kardiol Pol, 2017, 75(7): 666-673.
|
15 |
Avsar E. Comment on "Are neutrophil/lymphocyte ratio (NLR), platelet/lymphocyte ratio (PLR), and/or mean platelet volume (MPV) clinically useful as predictive parameters for preeclampsia?" [J]. J Matern Fetal Neonatal Med, 2021, 34(11): 1843.
|
16 |
曹丽, 李红梅. 中性粒细胞与淋巴细胞比值与子痫前期的相关性研究 [J]. 中国妇幼保健, 2018, 33(10): 2240-2242.
|
17 |
Wright D, Syngelaki A, Akolekar R, et al. Competing risks model in screening for pre-eclampsia by maternal characteristics and medical history [J]. Am J Obstet Gynecol, 2015, 213(62): e1-10.
|
18 |
Sahai K, Saraswathy S, Yadav TP, et al. Pre-eclampsia: molecular events to biomarkers [J]. Med J Armed Forces India, 2017, 73(2): 167-174.
|
19 |
尹学敬, 杨占辉. 外周血中炎性指标及血小板分布宽度与子痫前期的相关性研究 [J]. 河北医药, 2019, 41(19): 2918-2921.
|